Enterprise Value
7.705M
Cash
2.615M
Avg Qtr Burn
-2.615M
Short % of Float
4.36%
Insider Ownership
9.23%
Institutional Own.
16.16%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Twirla (levonorgestrel and ethinyl estradiol) transdermal system Details Contraceptive, Progestin and estrogen contraception | Approved Quarterly sales | |
AG890 Details Contraceptive, Progestin-only contraception | Phase 2 Update |